Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Study on Effective and Safe Concentrations of Ciprofol TCI in Different Age Groups
ChiCTR2600123334Phase 4Not yet recruiting
- Sponsor
- Chongqing University Cancer Hospital
- Start
- Apr 2026
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in thyroid neoplasm (5 arms), sponsored by Chongqing University Cancer Hospital. Primary endpoints: Success rate of total intravenous anesthesia induction and maintenance (Phase 2) and Plasma concentration (Cp) for successful induction and corresponding effect-site concentration (Ce) (Phase 1). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
thyroid neoplasm
Beyond the preview
Go deeper on ChiCTR2600123334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123334.